X0202 SCHEDULE 13G/A 0001140361-25-019057 0002066775 XXXXXXXX LIVE 2 Ordinary Shares, par value $0.0004 per share 05/28/2026 0002010499 Diginex Limited G28687104 25 Wilton Road, Victoria London, Greater London X0 SW1V 1LW Rule 13d-1(d) HBM IV, Inc. a DE 0 0 0 0 CO Fitch Group, Inc. a DE 0 0 0 0 CO Hearst Ratings II, Inc. a DE 0 0 0 0 CO Hearst Communications, Inc. a DE 0 0 0 0 CO Hearst Holdings, Inc. a DE 0 0 0 0 CO The Hearst Corporation a DE 0 0 0 0 CO The Hearst Family Trust a CA 0 0 0 0 OO Diginex Limited 25 Wilton Road, Victoria, London, Greater London, SW1V 1LW, United Kingdom This Statement is filed on behalf of each of the following persons: 1. HBM IV, Inc., a Delaware corporation ("HBM IV"); 2. Fitch Group, Inc., a Delaware corporation ("FGI"); 3. Hearst Ratings II, Inc., a Delaware corporation ("HRII"); 4. Hearst Communications, Inc., a Delaware corporation ("HCI"); 5. Hearst Holdings, Inc., a Delaware corporation ("HHI"); 6. The Hearst Corporation, a Delaware corporation ("THC"); and 7. The Hearst Family Trust, a testamentary trust (the "Trust"). The principal business office of each of HBM IV, HRII, HCI, HHI, THC and the Trust is 300 West 57th Street, New York, New York 10019. The principal business office of FGI is 33 Whitehall Street, New York, New York 10004. Each of HBM IV, FGI, HRII, HCI, HHI and THC is a Delaware corporation. The Trust is a testamentary trust that was probated in California. Y On May 28, 2026, HBM IV sold all of its remaining Ordinary Shares of the Issuer (the "Sale"). Prior to the Sale, HBM IV was the beneficial owner of Ordinary Shares of the Issuer. In 2026, HCI transferred the stock of HBM IV to its wholly-owned subsidiary HRII, and HRII immediately thereafter transferred the stock of HBM IV to its wholly-owned subsidiary, FGI. Pursuant to the definition of "beneficial owner" set forth in Rule 13d-3 under the Securities Exchange Act of 1934, as amended, each of HBM IV, FGI, HRII, HCI, HHI, THC and the Trust was deemed to beneficially own such securities. At the time of the Sale, (i) FGI, as the controlling stockholder of HBM IV, (ii) HRII, as the controlling stockholder of FGI, (iii) HCI, as the controlling stockholder of HRII, (iv) HHI, as the controlling stockholder of HCI, (v) THC, as the controlling stockholder of HHI, and (vi) the Trust, as the controlling stockholder of THC, each had the power to direct the voting and disposition of the Ordinary Shares of the Issuer held by HBM IV. Following the Sale, none of HBM IV, FGI, HRII, HCI, HHI, THC or the Trust directly or indirectly owns any Ordinary Shares of the Issuer nor may any of them be deemed to beneficially own such securities. HBM IV: 0% FGI: 0% HRII: 0% HCI: 0% HHI: 0% THC: 0% Trust: 0% HBM IV: 0 FGI: 0 HRII: 0 HCI: 0 HHI: 0 THC: 0 Trust: 0 HBM IV: 0 FGI: 0 HRII: 0 HCI: 0 HHI: 0 THC: 0 Trust: 0 N Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under _ 240.14a-11. HBM IV, Inc. /s/ Bruce Legorburu 08/14/2026 Fitch Group, Inc. /s/ Bruce Legorburu 08/14/2026 Hearst Ratings II, Inc. /s/ Mitchell I. Scherzer 08/14/2026 Hearst Communications, Inc. /s/ Mitchell I. Scherzer 08/14/2026 Hearst Holdings, Inc. /s/ Mitchell I. Scherzer 08/14/2026 The Hearst Corporation /s/ Mitchell I. Scherzer 08/14/2026 The Hearst Family Trust /s/ Mitchell I. Scherzer 08/14/2026